Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsReferences
- Practice Parameter update: management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding.Rep Qual Stand Subcommittee Ther Technol Assess Subcommittee Am Acad Neurol Am Epilepsy Soc. 2009; 73: 142-149
- Predictors of unintended pregnancy in women with epilepsy.Neurology. 2017; 88: 728-733
- Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy.Epileptic Disord. 2019; 21: 497-517
Hiilesmaa VK, Teramo KA. Fetal and Maternal Risks with Seizures. In Harden C, Thomas SV, Tomson T, editors. Epilepsy in Women. John Wiley & Sons. p. 115–127.
- Maternal complex partial seizure associated with fetal distress.Arch Neurol. 2005; 62: 1304-1305
- A maternal complex partial seizure in labor can affect fetal heart rate.Neurology. 1998; 51: 904-906
- SUDEP and epilepsy-related mortality in pregnancy.Epilepsia. 2014; 55: e72-e74
- Trends in maternal deaths from epilepsy in the United Kingdom: a 30-year retrospective review.Obstet Med. 2014; 7: 160-164
- Affect of seizures during gestation on pregnancy outcomes in women with epilepsy.Arch Neurol. 2009; 66: 979-984
- Changes in seizure frequency and antiepileptic therapy during pregnancy.N Engl J Med. 2020; 383: 2547-2556
- Management of epilepsy during pregnancy.Expert Rev Neurother. 2015; 15: 1171-1187
- Exposure to antiepileptic drugs in utero and child development: a prospective population-based study.Epilepsia. 2013; 54: 1462-1472
- Pregnancy, epilepsy, and women's issues.Continuum (Minneap Minn). 2013; 19: 697-714
- Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.J Neurol Neurosurg Psychiatr. 2014; 85: 1029-1034
- Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy.J Neurol. 2014; 261: 579-588
- Teratogenic effects of antiepileptic drugs.Lancet Neurol. 2012; 11: 803-813
- Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.Lancet Neurol. 2018; 17: 530-538
- The fetal safety of Levetiracetam: a systematic review.Reprod Toxicol. 2014; 46: 40-45
- Levetiracetam pregnancy registry: final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations.Birth Defects Res. 2019; 111: 872-887
- Comparative safety of antiepileptic drugs during pregnancy.Neurology. 2012; 78: 1692-1699
- Topiramate use in pregnancy and the birth prevalence of oral clefts.Pharmacoepidemiol Drug Saf. 2014; 23: 1017-1025
- Association between topiramate and zonisamide use during pregnancy and low birth weight.Obstet Gynecol. 2014; 123: 21-28
- Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.Lancet Neurol. 2011; 10: 609-617
- Zonisamide safety in pregnancy: data from the UK and Ireland epilepsy and pregnancy register.Seizure. 2021; 91: 311-315
- Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy.Neurology. 2020; 94: e1502-e1511
- Teratogenic effects of zonisamide.Seizure - Eur J Epilepsy. 2021; 91: 490
- Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP).Seizure. 2021; 93: 127-132
- Teratogenicity of antiepileptic dual therapy: dose-dependent, drug-specific, or both?.Neurology. 2018; 90: e790-e796
- Outcomes following exposure to the antiepileptic drug lacosamide during pregnancy – results from a global safety database (P5.231).Neurology. 2017; 88
- Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.Arch Neurol. 2011; 68: 1275-1281
- Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.Epilepsia. 2016; 57: 1048-1052
- Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.Lancet Neurol. 2013; 12: 244-252
- Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.Cochrane Database Syst Rev. 2014; 2014: Cd010236
- The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs.J Neurol Neurosurg Psychiatr. 2013; 84: 637-643
- Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.JAMA. 2013; 309: 1696-1703
- Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability.JAMA Neurol. 2022; 79: 672-681
- Enduring language deficits in children of women with epilepsy and the potential role of intrauterine exposure to antiepileptic drugs.Epilepsia. 2020; 61: 2442-2451
- IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.Neurology. 2015; 84: 382-390
- Neurodevelopmental outcomes in children exposed to newer antiseizure medications: a systematic review.Epilepsia. 2021; 62: 1765-1779
- In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.Neurology. 2014; 82: 213-221
- Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children.JAMA Neurol. 2018; 75: 663-671
- Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.Lancet. 1991; 338: 131-137
- Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy.J Neurol. 2008; 255: 1926-1931
- Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children.JAMA. 2013; 309: 570-577
- Folic acid supplements in pregnancy and severe language delay in children.JAMA. 2011; 306: 1566-1573
- Folic acid and risk of preterm birth, preeclampsia and fetal growth restriction among women with epilepsy: a prospective cohort study.Neurology. 2022; 99: e605-e615
- Cancer risk in children of mothers with epilepsy and high-dose folic acid use during pregnancy.JAMA Neurology. 2022; 79: 1130-1138
- Management of epilepsy during pregnancy: an update.Ther Adv Neurol Disord. 2016; 9: 118-129
- Model-Based Lamotrigine Clearance Changes During Pregnancy: Clinical Implication.Ann Clin Transl Neurol. 2014; 1: 99-106
- Antiseizure medication concentrations during pregnancy: results from the maternal outcomes and neurodevelopmental effects of antiepileptic drugs (MONEAD) study.JAMA Neurol. 2022; 79: 370-379
- Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications.Epilepsia. 2013; 54: 405-414
- Pharmacokinetics of valproate in pregnancy: mother-foetus-newborn.Pharm Weekbl Sci. 1992; 14: 114-117
- Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.Neurology. 2008; 70: 2130-2136
- Duration of breastfeeding and risk of SIDS: an individual participant data meta-analysis.Pediatrics. 2017; 140
- Breastfeeding protects against infectious diseases during infancy in industrialized countries. A systematic review.Matern Child Nutr. 2009; 5: 199-210
- Antiepileptic drug exposure in infants of breastfeeding mothers with epilepsy.JAMA Neurol. 2020; 77: 441-450
- Effects of breastfeeding in children of women taking antiepileptic drugs.Neurology. 2010; 75: 1954-1960